The Cancer Prevention & Research Institute of Texas (CPRIT) has released two new requests for applications (open through January 27, 2021) in its effort to develop a statewide clinical trials network that functions to speed development of new promising drugs and to increase access by cancer patients in Texas to state-of-the-art clinical trials of new treatment strategies.
The Clinical Trials Network Award (RFA R-21.2 CTNA) is designed to support an institution, organization, or physician group with an established clinical trials infrastructure and clinical trials portfolio to develop and oversee a limited network of cancer care facilities that currently lack adequate access to clinical trials or sufficient clinical trials infrastructure.
The Texas Clinical Trials Participation Program Award (RFA R-21.2 TCTPA) is designed to support an institution, organization, or physician group with an established clinical trials infrastructure and clinical trials portfolio to increase therapeutic cancer clinical trials by removing non-clinical out of pocket costs as barriers to participation.
These opportunities are exclusive to TxSCO members. For questions, please contact Nicole Dreabit, Executive Director, or click here for more information.